RNA populations in immunocompromised patients as reservoirs for novel norovirus variants

Journal of Virology

Volumn 88, Issue 24, 2014, Pages 14184-14196

  Vega, Everardo ^a   Donaldson, Eric ^b   Huynh, Jeremy ^b   Barclay, Leslie ^a   Lopman, Ben ^a   Baric, Ralph ^b   Chen, Luke F ^c   Vinjé, Jan ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b IL   (United States)

^c DUKE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 4; PROTEIN VP1; VIRUS RNA;

ADOLESCENT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BIOINFORMATICS; BONE MARROW TRANSPLANTATION; CASE REPORT; CHILD; CONTIG MAPPING; ENTROPY; FECES ANALYSIS; FEMALE; GENE DELETION; GENETIC CONSERVATION; GENETIC DRIFT; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME SIZE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; MALE; METAGENOMICS; MOLECULAR CLONING; MOLECULAR EVOLUTION; MUTATIONAL ANALYSIS; NONHUMAN; NOROVIRUS; NOROVIRUS GII 4 UNK1; NOROVIRUS GII 4 UNK2; NS2 GENE; NS3 GENE; NS4 GENE; NS5 GENE; NS6 GENE; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRESCHOOL CHILD; RNA ANALYSIS; RNA SEQUENCE; STOP CODON; VIRAL GASTROENTERITIS; VIRUS CARRIER; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS MUTATION; VIRUS STRAIN; VIRUS TITRATION; VP1 GENE; VP2 GENE; CALICIVIRUS INFECTION; CLASSIFICATION; DIARRHEA; DNA SEQUENCE; FECES; GENETICS; GENOTYPE; IMMUNOCOMPROMIZED PATIENT; INFANT; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; VIROLOGY;

NOROVIRUS;

ADOLESCENT; AGED; CALICIVIRIDAE INFECTIONS; DIARRHEA; EVOLUTION, MOLECULAR; FECES; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; MOLECULAR SEQUENCE DATA; NOROVIRUS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

EID: 84911489311     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02494-14     Document Type: Article

References (50)

1. Glass RI, Parashar UD, Estes MK. 2009. Norovirus gastroenteritis. N. Engl. J. Med. 361:1776-1785. http://dx.doi.org/10.1056/NEJMra0804575.
2. Patel MM, Hall AJ, Vinjé J, Parashar UD. 2009. Noroviruses: a comprehensive review. J. Clin. Virol. 44:1-8. http://dx.doi.org/10.1016/j.jcv.2008.10.009.
3. Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, Gray JJ, Letley LH, Rait G, Tompkins DS, O'Brien SJ, IID2 Study Executive Committee. 2012. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 61:69-77. http://dx.doi.org/10.1136/gut.2011.238386.
4. Payne DC, Vinjé J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, Hall CB, Chappell J, Bernstein DI, Curns AT, Wikswo M, Shirley SH, Hall AJ, Lopman B, Parashar UD. 2013. Norovirus and medically attended gastroenteritis in U.S. children. N. Engl. J. Med. 368:1121-1130. http://dx.doi.org/10.1056/NEJMsa1206589.
5. Trivedi TK, DeSalvo T, Lee L, Palumbo A, Moll M, Curns A, Hall AJ, Patel M, Parashar UD, Lopman BA. 2012. Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010. JAMA 308:1668-1675. http://dx.doi.org/10.1001/jama.2012.14023.
6. Bok K, Green KY. 2012. Norovirus gastroenteritis in immunocompromised patients. N. Engl. J. Med. 367:2126-2132. http://dx.doi.org/10.1056/NEJMra1207742.
7. van Asten L, van den Wijngaard C, van Pelt W, van de Kassteele J, Meijer A, van der Hoek W, Kretzschmar M, Koopmans M. 2012. Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J. Infect. Dis. 206:628-639. http://dx.doi.org/10.1093/infdis/jis415.
8. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. 2012. The roles of Clostridium difficile and norovirus among gastroenteritisassociated deaths in the United States, 1999-2007. Clin. Infect. Dis. 55: 216-223. http://dx.doi.org/10.1093/cid/cis386.
9. Green K. 2013. Caliciviridae: the noroviruses, p 583-609. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed, vol 1. Lippincott Williams & Wilkins, Philadelphia, PA.
10. Vinjé J. 2 July 2014. Advances in laboratory methods for detection and typing of norovirus. J. Clin. Microbiol. http://dx.doi.org/10.1128/JCM.01535-14.
11. Hasing ME, Lee BE, Preiksaitis JK, Tellier R, Honish L, Senthilselvan A, Pang XL. 2013. Emergence of a new norovirus GII.4 variant and changes in the historical biennial pattern of norovirus outbreak activity in Alberta, Canada, from 2008 to 2013. J. Clin. Microbiol. 51:2204-2211. http://dx.doi.org/10.1128/JCM.00663-13.
12. Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinjé J. 2014. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013. J. Clin. Microbiol. 52:147-155. http://dx.doi.org/10.1128/JCM.02680-13.
13. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, Vinje J, Baric RS. 2008. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 5:e31. http://dx.doi.org/10.1371/journal.pmed.0050031.
14. Siebenga JJ, Lemey P, Kosakovsky Pond SL, Rambaut A, Vennema H, Koopmans M. 2010. Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathog. 6:e1000884. http://dx.doi.org/10.1371/journal.ppat.1000884.
15. Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV, Kapikian AZ, Green KY. 2009. Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J. Virol. 83:11890-11901. http://dx.doi.org/10.1128/JVI.00864-09.
16. Bull RA, Eden JS, Rawlinson WD, White PA. 2010. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog. 6:e1000831. http://dx.doi.org/10.1371/journal.ppat.1000831.
17. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R. 2006. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344-348. http://dx.doi.org/10.1038/nature04388.
18. Graham RL, Becker MM, Eckerle LD, Bolles M, Denison MR, Baric RS. 2012. A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nat. Med. 18: 1820-1826. http://dx.doi.org/10.1038/nm.2972.
19. Gnädig NF, Beaucourt S, Campagnola G, Bordería AV, Sanz-Ramos M, Gong P, Blanc H, Peersen OB, Vignuzzi M. 2012. Coxsackievirus B3 mutator strains are attenuated in vivo. Proc. Natl. Acad. Sci. U. S. A. 109:2294-2303.
20. Levi LI, Gnädig NF, Beaucourt S, McPherson MJ, Baron B, Arnold JJ, Vignuzzi M. 2010. Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds. PLoS Pathog. 6:e1001163. http://dx.doi.org/10.1371/journal.ppat.1001163.
21. Pfeiffer JK, Kirkegaard K. 2005. Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog. 1:e11. http://dx.doi.org/10.1371/journal.ppat.0010011.
22. Motomura K, Yokoyama M, Ode H, Nakamura H, Mori H, Kanda T, Oka T, Katayama K, Noda M, Tanaka T, Takeda N, Sato H, Norovirus Surveillance Group of Japan. 2010. Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan. J. Virol. 84:8085-8097. http://dx.doi.org/10.1128/JVI.02125-09.
23. Eden JS, Hewitt J, Lim KL, Boni MF, Merif J, Greening G, Ratcliff RM, Holmes EC, Tanaka MM, Rawlinson WD, White PA. 2014. The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012. Virology 450-451:106-113. http://dx.doi.org/10.1016/j.virol.2013.12.005.
24. Nilsson M, Hedlund KO, Thorhagen M, Larson G, Johansen K, Ekspong A, Svensson L. 2003. Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J. Virol. 77: 13117-13124. http://dx.doi.org/10.1128/JVI.77.24.13117-13124.2003.
25. Carlsson B, Lindberg AM, Rodriguez-Díaz J, Hedlund KO, Persson B, Svensson L. 2009. Quasispecies dynamics and molecular evolution of human norovirus capsid P region during chronic infection. J. Gen. Virol. 90:432-441. http://dx.doi.org/10.1099/vir.0.005082-0.
26. Hoffmann D, Hutzenthaler M, Seebach J, Panning M, Umgelter A, Menzel H, Protzer U, Metzler D. 2012. Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients. Infect. Genet. Evol. 12:461-466. http://dx.doi.org/10.1016/j.meegid.2012.01.020.
27. Capizzi T, Makari-Judson G, Steingart R, Mertens WC. 2011. Chronic diarrhea associated with persistent norovirus excretion in patients with chronic lymphocytic leukemia: report of two cases. BMC Infect. Dis. 11:131. http://dx.doi.org/10.1186/1471-2334-11-131.
28. Siebenga JJ, Beersma MF, Vennema H, van Biezen P, Hartwig NJ, Koopmans M. 2008. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J. Infect. Dis. 198:994-1001. http://dx.doi.org/10.1086/591627.
29. Wingfield T, Gallimore CI, Xerry J, Gray JJ, Klapper P, Guiver M, Blanchard TJ. 2010. Chronic norovirus infection in an HIV-positive patient with persistent diarrhoea: a novel cause. J. Clin. Virol. 49:219-222. http://dx.doi.org/10.1016/j.jcv.2010.07.025.
30. Robles JD, Cheuk DK, Ha SY, Chiang AK, Chan GC. 2012. Norovirus infection in pediatric hematopoietic stem cell transplantation recipients: incidence, risk factors, and outcome. Biol. Blood Marrow Transplant. 18: 1883-1889. http://dx.doi.org/10.1016/j.bbmt.2012.07.005.
31. Frange P, Touzot F, Debré M, Héritier S, Leruez-Ville M, Cros G, Rouzioux C, Blanche S, Fischer A, Avettand-Fenoël V. 2012. Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies. J. Infect. Dis. 206:1269-1274. http://dx.doi.org/10.1093/infdis/jis498.
32. Debbink K, Lindesmith LC, Ferris MT, Swanstrom J, Beltramello M, Corti D, Lanzavecchia A, Baric RS. 2014. Within-host evolution results in antigenically distinct GII.4 noroviruses. J. Virol. 88:7244-7255. http://dx.doi.org/10.1128/JVI.00203-14.
33. Bull RA, Eden JS, Luciani F, McElroy K, Rawlinson WD, White PA. 2012. Contribution of intra-and interhost dynamics to norovirus evolution. J. Virol. 86:3219-3229. http://dx.doi.org/10.1128/JVI.06712-11.
34. Chan MC, Lee N, Ho WS, Law CO, Lau TC, Tsui SK, Sung JJ. 2012. Covariation of major and minor viral capsid proteins in norovirus genogroup II genotype 4 strains. J. Virol. 86:1227-1232. http://dx.doi.org/10.1128/JVI.00228-11.
35. Prosperi MC, Yin L, Nolan DJ, Lowe AD, Goodenow MM, Salemi M. 2013. Empirical validation of viral quasispecies assembly algorithms: state-of-the-art and challenges. Sci. Rep. 3:2837. http://dx.doi.org/10.1038/srep02837.
36. Vega E, Barclay L, Gregoricus N, Williams K, Lee D, Vinjé J. 2011. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg. Infect. Dis. 17:1389-1395. http://dx.doi.org/10.3201/eid1708.101837.
37. Vega E, Vinjé J. 2011. Novel GII.12 norovirus strain, United States, 2009-2010. Emerg. Infect. Dis. 17:1516-1518. http://dx.doi.org/10.3201/eid1708.110025.
38. Trujillo AA, McCaustland KA, Zheng DP, Hadley LA, Vaughn G, Adams SM, Ando T, Glass RI, Monroe SS. 2006. Use of TaqMan realtime reverse transcription-PCR for rapid detection, quantification, and typing of norovirus. J. Clin. Microbiol. 44:1405-1412. http://dx.doi.org/10.1128/JCM.44.4.1405-1412.2006.
39. Donaldson EF, Haskew AN, Gates JE, Huynh J, Moore CJ, Frieman MB. 2010. Metagenomic analysis of the viromes of three North American bat species: viral diversity among different bat species that share acommonhabitat. J. Virol. 84:13004-13018. http://dx.doi.org/10.1128/JVI.01255-10.
40. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL. 2012. Detecting individual sites subject to episodic diversifying selection. PLoS Genet. 8:e1002764. http://dx.doi.org/10.1371/journal.pgen.1002764.
41. Motomura K, Oka T, Yokoyama M, Nakamura H, Mori H, Ode H, Hansman GS, Katayama K, Kanda T, Tanaka T, Takeda N, Sato H, Norovirus Surveillance Group of Japan. 2008. Identification of monomorphic and divergent haplotypes in the 2006-2007 norovirus GII/4 epidemic population by genomewide tracing of evolutionary history. J. Virol. 82:11247-11262. http://dx.doi.org/10.1128/JVI.00897-08.
42. Sharp TM, Guix S, Katayama K, Crawford SE, Estes MK. 2010. Inhibition of cellular protein secretion by norwalk virus nonstructural protein p22 requires a mimic of an endoplasmic reticulum export signal. PLoS One 5:e13130. http://dx.doi.org/10.1371/journal.pone.0013130.
43. Hyde JL, Mackenzie JM. 2010. Subcellular localization of the MNV-1 ORF1 proteins and their potential roles in the formation of the MNV-1 replication complex. Virology 406:138-148. http://dx.doi.org/10.1016/j.virol.2010.06.047.
44. Debbink K, Donaldson EF, Lindesmith LC, Baric RS. 2012. Genetic mapping of a highly variable norovirus GII. 4 blockade epitope: potential role in escape from human herd immunity. J. Virol. 86:1214-1226. http://dx.doi.org/10.1128/JVI.06189-11.
45. Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, Debbink K, Lanzavecchia A, Baric RS. 2012. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog. 8:e1002705. http://dx.doi.org/10.1371/journal.ppat.1002705.
46. Lindesmith LC, Costantini V, Swanstrom J, Debbink K, Donaldson EF, Vinjé J, Baric RS. 2013. Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes. J. Virol. 87:2803-2813. http://dx.doi.org/10.1128/JVI.03106-12.
47. Lindesmith LC, Donaldson EF, Beltramello M, Pintus S, Corti D, Swanstrom J, Debbink K, Jones TA, Lanzavecchia A, Baric RS. 2014. Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope. J. Virol. 88:8826-8842. http://dx.doi.org/10.1128/JVI.01192-14.
48. Barclay L, Park GW, Vega E, Hall A, Parashar U, Vinjé J, Lopman B. 2014. Infection control for norovirus. Clin. Microbiol. Infect. 20:731-740. http://dx.doi.org/10.1111/1469-0691.12674.
49. Costantini VP, Whitaker T, Barclay L, Lee D, McBrayer TR, Schinazi RF, Vinjé J. 2012. Antiviral activity of nucleoside analogues against norovirus. Antivir. Ther. 17:981-991. http://dx.doi.org/10.3851/IMP2229.
50. Kroneman A, Vega E, Vennema H, Vinjé J, White PA, Hansman G, Green K, Martella V, Katayama K, Koopmans M. 2013. Proposal for a unified norovirus nomenclature and genotyping. Arch. Virol. 158:2059-2068. http://dx.doi.org/10.1007/s00705-013-1708-5.